Cargando…
Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells
Immune checkpoint blockade (ICB) has become one of the most promising approaches to activating antitumor immunity. However, only a small subset of patients with breast cancer benefit from ICB treatment. To improve the therapeutic effect in the clinic, precision immunotherapy is proposed to accuratel...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178503/ https://www.ncbi.nlm.nih.gov/pubmed/33932112 http://dx.doi.org/10.1002/cam4.3902 |